These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 25907107)

  • 41. Genetics and expression analysis of the specificity protein 4 gene (SP4) in patients with Alzheimer's disease and frontotemporal lobar degeneration.
    Villa C; Ghezzi L; Fenoglio C; Clerici F; Marcone A; Benussi L; Ghidoni R; Gallone S; Serpente M; Cantoni C; Ridolfi E; Bonsi R; Cerami C; Cappa S; Binetti G; Franceschi M; Rainero I; Mariani C; Bresolin N; Scarpini E; Galimberti D
    J Alzheimers Dis; 2012; 31(3):537-42. PubMed ID: 22614877
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association of the Asn306Ser variant of the SP4 transcription factor and an intronic variant in the beta-subunit of transducin with digenic disease.
    Gao YQ; Danciger M; Ozgul RK; Gribanova Y; Jacobson S; Farber DB
    Mol Vis; 2007 Feb; 13():287-92. PubMed ID: 17356515
    [TBL] [Abstract][Full Text] [Related]  

  • 43. PDE10A inhibition reverses subchronic PCP-induced deficits in attentional set-shifting in rats.
    Rodefer JS; Murphy ER; Baxter MG
    Eur J Neurosci; 2005 Feb; 21(4):1070-6. PubMed ID: 15787711
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The dopamine D4 receptor is essential for hyperactivity and impaired behavioral inhibition in a mouse model of attention deficit/hyperactivity disorder.
    Avale ME; Falzone TL; Gelman DM; Low MJ; Grandy DK; Rubinstein M
    Mol Psychiatry; 2004 Jul; 9(7):718-26. PubMed ID: 14699433
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hyperactivity and learning deficits in transgenic mice bearing a human mutant thyroid hormone beta1 receptor gene.
    McDonald MP; Wong R; Goldstein G; Weintraub B; Cheng SY; Crawley JN
    Learn Mem; 1998; 5(4-5):289-301. PubMed ID: 10454355
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Phencyclidine exacerbates attentional deficits in a neurodevelopmental rat model of schizophrenia.
    Le Pen G; Grottick AJ; Higgins GA; Moreau JL
    Neuropsychopharmacology; 2003 Oct; 28(10):1799-809. PubMed ID: 12784101
    [TBL] [Abstract][Full Text] [Related]  

  • 47. O-GlcNAc modification of Sp3 and Sp4 transcription factors negatively regulates their transcriptional activities.
    Ha C; Lim K
    Biochem Biophys Res Commun; 2015 Nov; 467(2):341-7. PubMed ID: 26431879
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of brain-behavior phenotypying of genetically-engineered mice on research of neuropsychiatric disorders.
    Takao K; Yamasaki N; Miyakawa T
    Neurosci Res; 2007 Jun; 58(2):124-32. PubMed ID: 17524507
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The selective serotonin-2A receptor antagonist M100907 reverses behavioral deficits in dopamine transporter knockout mice.
    Barr AM; Lehmann-Masten V; Paulus M; Gainetdinov RR; Caron MG; Geyer MA
    Neuropsychopharmacology; 2004 Feb; 29(2):221-8. PubMed ID: 14603268
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Translational Rodent Paradigms to Investigate Neuromechanisms Underlying Behaviors Relevant to Amotivation and Altered Reward Processing in Schizophrenia.
    Young JW; Markou A
    Schizophr Bull; 2015 Sep; 41(5):1024-34. PubMed ID: 26194891
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Motivational Deficits and Negative Symptoms in Schizophrenia: Concepts and Assessments.
    Reddy LF; Horan WP; Green MF
    Curr Top Behav Neurosci; 2016; 27():357-73. PubMed ID: 26164592
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transcription factor Sp4 regulates dendritic patterning during cerebellar maturation.
    Ramos B; Gaudillière B; Bonni A; Gill G
    Proc Natl Acad Sci U S A; 2007 Jun; 104(23):9882-7. PubMed ID: 17535924
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Behavioral alterations in a mouse model of temporal lobe epilepsy induced by intrahippocampal injection of kainate.
    Gröticke I; Hoffmann K; Löscher W
    Exp Neurol; 2008 Sep; 213(1):71-83. PubMed ID: 18585709
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Effectiveness and Tolerability of Central Nervous System Stimulants in School-Age Children with Attention-Deficit/Hyperactivity Disorder and Disruptive Mood Dysregulation Disorder Across Home and School.
    Baweja R; Belin PJ; Humphrey HH; Babocsai L; Pariseau ME; Waschbusch DA; Hoffman MT; Akinnusi OO; Haak JL; Pelham WE; Waxmonsky JG
    J Child Adolesc Psychopharmacol; 2016 Mar; 26(2):154-63. PubMed ID: 26771437
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Methylphenidate normalises activation and functional connectivity deficits in attention and motivation networks in medication-naïve children with ADHD during a rewarded continuous performance task.
    Rubia K; Halari R; Cubillo A; Mohammad AM; Brammer M; Taylor E
    Neuropharmacology; 2009 Dec; 57(7-8):640-52. PubMed ID: 19715709
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intrauterine environment-genome interaction and children's development (4): Brain-behavior phenotypying of genetically-engineered mice using a comprehensive behavioral test battery on research of neuropsychiatric disorders.
    Takao K; Miyakawa T
    J Toxicol Sci; 2009; 34 Suppl 2():SP293-305. PubMed ID: 19571483
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Modeling neurodevelopmental cognitive deficits in tasks with cross-species translational validity.
    Cope ZA; Powell SB; Young JW
    Genes Brain Behav; 2016 Jan; 15(1):27-44. PubMed ID: 26667374
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cloning of the human glycine transporter type 1: molecular and pharmacological characterization of novel isoform variants and chromosomal localization of the gene in the human and mouse genomes.
    Kim KM; Kingsmore SF; Han H; Yang-Feng TL; Godinot N; Seldin MF; Caron MG; Giros B
    Mol Pharmacol; 1994 Apr; 45(4):608-17. PubMed ID: 8183239
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neuropsychological functioning in girls with attention-deficit/hyperactivity disorder with and without learning disabilities.
    Seidman LJ; Biederman J; Valera EM; Monuteaux MC; Doyle AE; Faraone SV
    Neuropsychology; 2006 Mar; 20(2):166-77. PubMed ID: 16594777
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Are there attentional deficits in people putatively at risk for affective disorders?
    Meyer TD; Blechert J
    J Affect Disord; 2005 Jan; 84(1):63-72. PubMed ID: 15620386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.